Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...
SCHD said that the partnership will allow expanded clinical services, enabling the health department to provide HIF and ...
A new strain of gonorrhea has emerged, causing significant concern among health professionals due to its resistance to traditional treatments. This sexually ...
The FDA granted clearance with a CLIA waiver for the cobas liat sexually transmitted infection (STI) assay, Roche announced; ...
Ghanaian women have been urged to take screening for human papillomavirus (HPV) infection seriously as cases of cervical cancer (CC) continue to soar in the country.
Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.
Clinical trials (also called medical research and research studies) are used to determine whether new drugs/treatments are ...
Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection ...
As supporters of Paul’s bill pointed out Thursday, the bill is as much about stripping the organization’s funding for ...
The agreement would allow SCHD to connect students with clinicians to expand access to screenings and care for middle and high school students.
The Alabama Department of Public Health is investigating some reports of adverse reactions to injections of the antibiotic ceftriaxone, or Rocephin, but a local health provider said she has seen no ...
A cervical cancer screening - which used to be known as a 'smear test' - is available for women and anyone with a cervix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback